Advancing antimicrobial susceptibility testing in body fluid-associated infections: a focus on direct testing for timely and targeted therapeutic interventions. Microbiologia Medica, [S. l.], v. 40, n. 1, 2025. DOI: 10.4081/mm.2025.13602. Disponível em: https://www.pagepressjournals.org/mm/article/view/13602. Acesso em: 22 apr. 2026.